Literature DB >> 33909692

Fear of pain moderates the relationship between self-reported fatigue and methionine allele of catechol-O-methyltransferase gene in patients with fibromyalgia.

David Ferrera1, Francisco Mercado1, Irene Peláez1, David Martínez-Iñigo1, Roberto Fernandes-Magalhaes1, Paloma Barjola1, Carmen Écija1, Gema Díaz-Gil2, Francisco Gómez-Esquer2.   

Abstract

Previous research has shown a consistent association among genetic factors, psychological symptoms and pain associated with fibromyalgia. However, how these symptoms interact to moderate genetic factors in fibromyalgia has rarely been studied to date. The present research investigates whether psychological symptoms can moderate the effects of catechol-O-methyltransferase on pain and fatigue. A total of 108 women diagnosed with fibromyalgia and 77 healthy control participants took part in the study. Pain, fatigue, and psychological symptoms (anxiety, depression, pain catastrophizing, fear of pain and fear of movement) were measured by self-report questionnaires. Two types of statistical analyses were performed; the first was undertaken to explore the influences of COMT genotypes on clinical symptoms by comparing patients with fibromyalgia and healthy controls. In the second analysis, moderation analyses to explore the role of psychological symptoms as potential factors that moderate the relationship between pain/fatigue and COMT genotypes were performed. The main results indicated that patients carrying the Met/Met genotype reported significantly higher levels of fatigue than heterozygote carriers (i.e., Met/Val genotype) and higher levels of fatigue, but not significantly different, than Val homozygote carriers. Among patients with fibromyalgia carrying methionine alleles (i.e., Met/Met + Met/Val carriers), only those who scored high on medical fear of pain, experienced an intensified feeling of fatigue. Thus, the present research suggests that fear of pain, as a psychological symptom frequently described in fibromyalgia may act as a moderating factor in the relationship between the Met allele of the COMT gene and the increase or decrease in self-reported fatigue. Although further research with wider patient samples is needed to confirm the present findings, these results point out that the use of psychological interventions focused on affective symptomatology might be a useful tool to reduce the severity of fibromyalgia.

Entities:  

Year:  2021        PMID: 33909692     DOI: 10.1371/journal.pone.0250547

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  3 in total

1.  Working memory dysfunction in fibromyalgia is associated with genotypes of the catechol- O-methyltransferase gene: an event-related potential study.

Authors:  David Ferrera; Francisco Gómez-Esquer; Irene Peláez; Paloma Barjola; Roberto Fernandes-Magalhaes; Alberto Carpio; María Eugenia De Lahoz; María Carmen Martín-Buro; Francisco Mercado
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-09-13       Impact factor: 5.760

2.  Interplay between genetics and lifestyle on pain susceptibility in women with fibromyalgia: the al-Ándalus project.

Authors:  Fernando Estévez-López; Juan M Guerrero-González; Diego Salazar-Tortosa; Daniel Camiletti-Moirón; Blanca Gavilán-Carrera; Virginia A Aparicio; Pedro Acosta-Manzano; Inmaculada C Álvarez-Gallardo; Víctor Segura-Jiménez; Alberto Soriano-Maldonado; Rinie Geenen; Manuel Delgado-Fernández; Luis J Martínez-González; Jonatan R Ruiz; María J Álvarez-Cubero
Journal:  Rheumatology (Oxford)       Date:  2022-08-03       Impact factor: 7.046

3.  Electrophysiological indices of pain expectation abnormalities in fibromyalgia patients.

Authors:  Paloma Barjola; Irene Peláez; David Ferrera; José Luis González-Gutiérrez; Lilian Velasco; Cecilia Peñacoba-Puente; Almudena López-López; Roberto Fernandes-Magalhaes; Francisco Mercado
Journal:  Front Hum Neurosci       Date:  2022-09-30       Impact factor: 3.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.